Clinical Trial Update: Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating semi-individualised Chinese medicine as an adjuvant treatment for diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: The University of Hong Kong | Conditions: Diabetic Nephropathies | Phase 2, Phase 3 | Status: UNKNOWN